Dihydromyricetin ameliorates hyperuricemia through inhibiting uric acid reabsorption
Journal of the Science of Food and Agriculture · 2025
DOI: 10.1002/jsfa.14126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, 2025. Verfasst von Ze-Rui Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Resources, Environment and Chemistry, Chuxiong Normal University, Chuxiong, China. Hauptthemen laut MEDLINE: Hyperuricemia, Flavonols, Uric Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Major Science and Technology Project of Yunnan Province, Reserve Talents of Young and Middle-aged Academic and Technical Leaders in Yunnan Province (202305AC160007), Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology (202407AD110002).
Abstract (Originalsprache)
BACKGROUND Hyperuricemia (HUA) is a chronic disease caused by abnormal purine metabolism with high prevalence. Dihydromyricetin (DMY) is a natural flavonoid that is abundant in plants, such as vine tea, grapes and bayberry. DMY has been shown to possess multiple biological properties, but its anti‐HUA effect remains underexplored. In the present study, the regulatory effects of DMY on HUA and its complications and mechanism were investigated. RESULTS DMY (10 and 20 μmol L −1 ) treatment significantly reduced xanthine oxidase (XOD) expression and uric acid (UA) synthesis in normal human liver cell strain cells, and intraperitoneal administration of DMY (100 mg kg −1 ) also significantly reduced serum UA and the expression of hepatic XOD in HUA mice. After DMY treatment for 12 consecutive days, the uricosuric protein, ATP‐binding cassette subfamily G member 2, was upregulated, and reabsorption proteins, including urate transporter 1 and glucose transporter 9, were downregulated, which was consistent with the results of monosodium urate‐induced HUA in human renal tubular epithelial cell line and human colon adenocarcinoma cell line cell models. In addition, DMY significantly ameliorated HUA‐induced renal injury, and foot edema induced by monosodium urate. The nucleotide‐binding oligomerization domain‐like receptor family containing pyrin domain 3 (NLRP3) inflammasome was activated in HUA mice as evidenced by upregulation of NLRP3, caspase‐1, ACS, TNF‐ α and IL‐1 β in the kidney and foot, which was significantly suppressed by DMY treatment. CONCLUSION Collectively, these findings suggested that DMY may play important roles in experimental HUA. © 2025 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Resources, Environment and Chemistry, Chuxiong Normal University, Chuxiong, China.
- Key Laboratory of Pu-erh Tea Science, Ministry of Education, College of Science, College of Food Science and Technology, Yunnan Agricultural University, Kunming, China.
- College of Food Science and Technology, Nanjing Agricultural University, Nanjing, China.
- School of Chinese Materia Medica and Yunnan Key Laboratory of Southern Medicinal Resource, School of Basic Medicine, Yunnan University of Chinese Medicine, Kunming, China.
- Yunnan Academy of Scientific & Technical Information, Kunming, China.
- Yunnan Characteristic Plant Extraction Laboratory Co., Ltd; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Key Laboratory of Research and Development for Natural Products; Scho…
ORCID-Profile: Ze-Rui Sun, Yun-Li Zhao
Förderung
- Major Science and Technology Project of Yunnan Province
- Reserve Talents of Young and Middle-aged Academic and Technical Leaders in Yunnan Province (202305AC160007)
- Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology (202407AD110002)
- Yun-ling Scholarship No. XDYC-YLXZ-2022-0025
- Project of Yunnan Characteristic Plant Screening and R&D Service CXO Platform
Zitieren
APA
Sun, Z. R., Peng, H. Z., Fan, M. S., Chang, D., Wang, M. Y., An, M. F., Zhang, L. J., Zan, R., Sheng, J., Zhao, Y. L., & Wang, X. J. (2025). Dihydromyricetin ameliorates hyperuricemia through inhibiting uric acid reabsorption. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.14126
Vancouver
Sun ZR, Peng HZ, Fan MS, Chang D, Wang MY, An MF, et al. Dihydromyricetin ameliorates hyperuricemia through inhibiting uric acid reabsorption. Journal of the Science of Food and Agriculture. 2025. doi:10.1002/jsfa.14126
BibTeX
@article{Sun2025,
author = {Sun, Ze-Rui and Peng, Hui-Zhen and Fan, Mao-Si and Chang, Dong and Wang, Ming-Yue and An, Meng-Fei and Zhang, Li-Juan and Zan, Rui and Sheng, Jun and Zhao, Yun-Li and Wang, Xuan-Jun},
title = {Dihydromyricetin ameliorates hyperuricemia through inhibiting uric acid reabsorption},
journal = {Journal of the Science of Food and Agriculture},
year = {2025},
doi = {10.1002/jsfa.14126}
}
EUVIMED